[Research Progress of Non-coding RNAs in the Regulation of Multiple Myeloma Bone Disease--Review]

Su-Mei Li1, Man-Ya Yu1, Xing Cui2

  • 1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250011, Shandong Province, China.

Insights

Non-coding RNAs are key regulators of bone remodeling in multiple myeloma bone disease. Targeting these molecules offers a promising new avenue for treating persistent bone lesions in patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bone Biology

Background:

  • Multiple myeloma bone disease is a frequent complication that worsens prognosis and quality of life.
  • This bone disease involves an imbalance in bone remodeling, contributing to myeloma progression.
  • Existing treatments often fail to heal bone lesions, even in remission, due to suppressed osteoblast activity.

Purpose of the Study:

  • To review recent advances in understanding non-coding RNAs in multiple myeloma bone disease.
  • To highlight the role of non-coding RNAs in regulating gene expression and signaling pathways involved in bone remodeling.
  • To explore non-coding RNAs as potential therapeutic targets for multiple myeloma bone disease.

Main Methods:

  • Literature review of recent studies on non-coding RNAs and multiple myeloma bone disease.
  • Analysis of research on non-coding RNA regulation of gene expression in bone remodeling.
  • Synthesis of findings on the role of non-coding RNAs in osteoblast activity and bone healing.

Main Results:

  • Non-coding RNAs significantly influence the imbalance of bone remodeling in multiple myeloma.
  • These molecules regulate critical genes and signaling pathways affecting bone metabolism.
  • Non-coding RNAs are implicated in the failure of bone lesions to heal in myeloma patients.

Conclusions:

  • Non-coding RNAs are crucial players in the pathogenesis of multiple myeloma bone disease.
  • Dysregulation of non-coding RNAs contributes to impaired bone healing and osteoblast suppression.
  • Non-coding RNAs represent a novel and promising field for therapeutic intervention in multiple myeloma bone disease.

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...